BioSpace News Archive

Job Trends

Oklahoma Proton Center Reopens After Equipment Upgrades

Oklahoma Proton Center, LLC reopened yesterday for treatment after a brief shutdown.

April 23, 2019
·
3 min read
Policy

Notice to the media - Government of Canada takes further steps to address the opioid crisis in British Columbia

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will announce investments to address the opioids crisis in B.C.

April 23, 2019
·
1 min read
Deals

Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call

Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the first quarter 2019 on Tuesday, May 7 at 4:30 p.m. ET / 1:30 p.m. PT.

April 23, 2019
·
2 min read
Deals

Jazz Pharmaceuticals to Report 2019 First Quarter Financial Results on May 7, 2019

Jazz Pharmaceuticals plc announced that it will report its 2019 first quarter financial results on Tuesday, May 7, 2019, after the close of the financial markets.

April 23, 2019
·
2 min read
Business

Accuray Reports Fiscal 2019 Third Quarter Results

Accuray Incorporated reported its financial results for the third quarter of fiscal 2019 ended March 31, 2019.

April 23, 2019
·
14 min read
Drug Development

Sheppard Mullin Adds Life Sciences IP Duo in Del Mar

Firm Continues Expansion of IP Practice with Two Patent Prosecutors

April 23, 2019
·
4 min read
Deals

Intersect ENT to Report First Quarter 2019 Financial Results

Intersect ENT, Inc. announced that it will release first quarter financial results on May 6, 2019.

April 23, 2019
·
1 min read
Genetown

AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain

AVEO Oncology announced the triggering of a $2 million milestone payment to AVEO from EUSA Pharma.

April 23, 2019
·
8 min read
Drug Development

Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback

SLATE Phase 1 clinical study may be accelerated by up to six months from the company’s prior expectations by leveraging pre-clinical data generated for the original GRANITE Investigational New Drug (IND) application.

April 23, 2019
·
5 min read
Policy

Notice to the media - Minister of Health to announce funding for immunization

As part of National Immunization Awareness Week, the Honourable Ginette Petitpas Taylor, federal Minister of Health, will announce funding to help improve vaccination rates.

April 23, 2019
·
1 min read